COMP <GO>
NBP vs SPRB // 10Y YIELD & FRED MACRO BETA
NovaBridge Biosciences (NASDAQ) VS. Spruce Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: NBP 1
— SPRB 2
■ METRIC PARITY
LAST: $1.07 (-10.46%) • MKT CAP: $137.9M
macro-sensitivity
—
LAST: $44.55 (-3.97%) • MKT CAP: $133.3M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NBP VS. SPRB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NBP | SPRB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -24.77% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 4/9 | -3.00 | SPRB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.5 | 52.1 | -14.60 | SPRB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $137.9M | $133.3M | $4.6M | NBP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NBP REV | SPRB REV | NBP GROSS % | SPRB GROSS % | NBP FCF | SPRB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $264.0M | $102.2M | — | — | — | -$33.3M |
| FY 2024 | $144.0M | $4.9M | — | — | — | -$56.0M |
| FY 2023 | $632.0K | $10.1M | — | — | -$183.8M | -$33.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NBP // BETA —
SPRB // BETA —